Effect of the FE2+ chelation by 2,2′-dipyridyl in the doxorubicin-induced lethality in breast tumor cell lines-Reference-Cited by-同舟云学术

Effect of the FE2+ chelation by 2,2′-dipyridyl in the doxorubicin-induced lethality in breast tumor cell lines

Published:2018-01 Issue: Volume:192 Page:128-135
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Bernardes Jéssica R.,Faria Caroline C.,Andrade Iris S.,Ferreira Andrea Claudia Freitas,Carvalho Denise P.,Leitão Alvaro C.,de Alencar Tatiana A.M.,Fortunato Rodrigo S.

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro

Fundação do Câncer

Coordenação de Aperfeiçoamento de Pessoal de Nível superior

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference49 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005

2. The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays;Smith;Mol. Cancer Ther.,2006

3. Doxorubicin resistance in breast cancer is driven by light at night-induced disruption of the circadian melatonin signal;Xiang;J. Pineal Res.,2015

4. The role of iron in anthracycline cardiotoxicity;Gammella;Front. Pharmacol.,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and Synthesis of Poly(2,2′-Bipyridyl) Ligands for Induction of Cell Death in Cancer Cells: Control of Anticancer Activity by Complexation/Decomplexation with Biorelevant Metal Cations;Inorganic Chemistry;2023-08-29

2. An iron-containing ferritin-based nanosensitizer for synergistic ferroptosis/sono-photodynamic cancer therapy;Journal of Materials Chemistry B;2023

3. Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells;Cancer Chemotherapy and Pharmacology;2022-02-12

4. Aberrantly expressed PLOD 1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target;Molecular Oncology;2019-06-27